Control group:Hepatectomy

2 trials

Sponsors

The First Affiliated Hospital of Dalian Medical University, the Third Affiliated Hospital, Naval Medical University

Conditions

Hepatocellular carcinomahepatocellular carcinoma

Phase 2

Efficacy and safety of adebrelimab combined with lenvatinib as neoadjuvant therapy for resectable hepatocellular carcinoma: a randomized controlled open-label phase II study

RecruitingChiCTR2400080080

The First Affiliated Hospital of Dalian Medical Universityhepatocellular carcinoma

Start: 2024-01-23Updated: 2024-09-30

Prospective randomized controlled study on whether TACE combined with PVE can reduce the recurrence rate of large liver cancer after surgery

RecruitingChiCTR2400090666

the Third Affiliated Hospital, Naval Medical UniversityHepatocellular carcinoma

Start: 2024-04-25Updated: 2024-10-15